United States · FDA National Drug Code directory

Fluoxetine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
83209-721_18e9f058-31ba-cc99-e063-6294a90a0fee
Product NDC
83209-721
Form
CAPSULE
Composition / generic term
Fluoxetine
Labeler
Boswell Pharmacy Services LLC d/b/a BPS Wholesale
Marketing category
ANDA
Marketing start / end (source format)
20240520
Source listing expiry
20261231

Source-listed ingredients

  • FLUOXETINE HYDROCHLORIDE — 20 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 6 CAPSULE in 1 BLISTER PACK (83209-721-06) · 83209-721-06
  • 10 CAPSULE in 1 BLISTER PACK (83209-721-10) · 83209-721-10
  • 15 CAPSULE in 1 BLISTER PACK (83209-721-15) · 83209-721-15
  • 20 CAPSULE in 1 BLISTER PACK (83209-721-20) · 83209-721-20
  • 30 CAPSULE in 1 BLISTER PACK (83209-721-30) · 83209-721-30
  • 60 CAPSULE in 1 BLISTER PACK (83209-721-60) · 83209-721-60

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →